期刊文献+

探讨脓毒症诊断和治疗新策略 被引量:4

New strategies for diagnosis and treatment of sepsis
下载PDF
导出
作者 崔德健
机构地区 解放军第
出处 《中国呼吸与危重监护杂志》 CAS 2004年第3期131-133,共3页 Chinese Journal of Respiratory and Critical Care Medicine
  • 相关文献

参考文献14

  • 1Fitch JC,Rollins S,Matis L,et al.Pharmacology and biological efficacy of a recombinant,humanized,single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass.Circulation,1999;100:249
  • 2Riedemann NC,Guo RF,Ward PA.The enigma of sepsis.J Clin Invest,2003;112:460-467
  • 3Czermak BJ,Sarma V,Pierson CL,et al.Protective effects of C5a blockade in sepsis.Nat Med,1999;5:788-792
  • 4Coopersmith CM,Stromberg PE,Dunne WM,et al.Inhibition of intestinal epithelial apoptosis and survival in a murine model of pneumonia-induced sepsis.JAMA,2002;287:1716-1721
  • 5Rivers E,Nguyen B,Havstad S,et al.Early goal-directed therapy in the treatment of severe sepsis and septic shock.N Eng J Med,2001;345:1368-1377
  • 6Van den Berghe G,Wouters P,Weekers F,et al.Intensive insulin therapy in the critically ill patients.N Eng J Med,2001;345:1359-1367
  • 7Martin GS,Mannino DM,Eaton S,et al.The epidemiology of sepsis in the United States from 1979 through 2000.N Eng J Med,2003;348:1546-1554
  • 8Riedemann NC,Guo RF,Ward PA.Novel strategies for the treatment of sepsis.Nat Med,2003;9:517-524
  • 9Bone RC,Sprung CL,Sibbald WJ.Definitions for sepsis and organ failure.Crit Care Med,1992;20:724-726
  • 10Levy MM,Fink MP,Marshall JC,et al.2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.Crit Care Med,2003;31:1250-1256

同被引文献53

  • 1邓志雄,包宇旺,林辛锋,肖荔生.核转录因子-κB及一氧化氮在急性肺损伤发生中的作用[J].中国呼吸与危重监护杂志,2004,3(4):248-251. 被引量:14
  • 2钱桂生.在实践中提高对急性肺损伤和急性呼吸窘迫综合征新概念的认识[J].中国呼吸与危重监护杂志,2002,1(4):199-201. 被引量:33
  • 3Andrews P, Azoulay E, Antonelli M, et al. Year in review in Intensive Care Medicine, 2006. II. hffections and sepsis, haemodynamics, elderly, invasive and noninvasive mechanical ventilation, weaning, ARDS. Intensive Care Med, 2007,33 : 214- 229.
  • 4Shimizu J, Yamazaki S, Takahashi T, et al. Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self- tolerance. Nat Immuno1,2002,3 : 135-142.
  • 5Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ ATS/SIS international sepsis definitions conference. Crit Care Med, 2003,31 : 1250-1256.
  • 6Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic selftolerance maintained by cell expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune disease. Immunol, 1995,155,1151-1164.
  • 7Wisnoski N, Chung CS, Chen Y. The Contribution of CD4+ CD25 + T-Regulatory-Cells to immune suppression in sepsis. Shock, 2007, 27:251-257.
  • 8Monneret G, Debard AL, Venet F,et al. Marked elevation of human circulating CD4+ CD25+ regulatory T cells in sepsis induced immunoparalysis. Crit Care Med ,2003,31:2068-2071.
  • 9Von Boehmer H. Mechanisms of suppression by suppressor T cells. Nat hnmuno1,2005 ,6 :338-344.
  • 10Venet F,Pachot A,Debard AL. Human CD4+ CD25 + Regulatory T lymphocytes inhibit lipopolysaccharide-induced monocyte survival through a Fas/Fas ligand-dependent mechanism. J Immunol,2006, 177:6540-6547.

引证文献4

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部